Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan

Paper. Raffa RB. Cureus, 13 Sep 2026.

Tags: Review, Psilocybin, MDMA, LSD, Ibogaine, Depression, Addiction.